Serum microrna biomarkers for detection of non-small cell lung cancer

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Hennessey, Patrick T ^a   Sanford, Tiffany ^b   Choudhary, Ashish ^b   Mydlarz, Wojciech W ^a   Brown, David ^c   Adai, Alex Tamas ^b   Ochs, Michael F ^a   Ahrendt, Steven A ^d   Mambo, Elizabeth ^b   Califano, Joseph A ^a,e  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b ASURAGEN INC   (United States)

^c SYNLOGIC   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e GREATER BALTIMORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 15B; MICRORNA 27B; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; AFRICAN AMERICAN; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD ANALYSIS; CANCER STAGING; CAUCASIAN; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; EARLY DIAGNOSIS; ETHNIC DIFFERENCE; FEMALE; HISPANIC; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PREDICTIVE VALUE; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; BLOOD; LUNG TUMOR; MIDDLE AGED;

NUCLEOPOLYHEDROVIRUS;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84863415612     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032307     Document Type: Article

References (32)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Centers for Disease Control and Prevention (CDC) (2007) Cigarette smoking among adults-United States, 2006. MMWR Morb Mortal Wkly Rep 56: 1157-1161.
3. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, et al. (2006) Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355: 1763-1771.
4. Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, et al. (2011) The National Lung Screening Trial: overview and study design. Radiology 258: 243-253.
5. New York Early Lunc Cancer Action Project Investigators (2007) CT Screening for lung cancer: diagnoses resulting from the New York Early Lung Cancer Action Project. Radiology 243: 239-249.
6. Peltier HJ, Latham GJ, (2008) Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14: 844-852.
7. Bach PB, Jett JR, Pastorino U, Tockman MS, Swensen SJ, et al. (2007) Computed tomography screening and lung cancer outcomes. JAMA 297: 953-961.
8. Miettinen OS, (2000) Screening for lung cancer: can it be cost-effective? CMAJ 162: 1431-1436.
9. Welch HG, Black WC, (2010) Overdiagnosis in cancer. J Natl Cancer Inst 102: 605-613.
10. Welch HG, Woloshin S, Schwartz LM, Gordis L, Gotzsche PC, et al. (2007) Overstating the evidence for lung cancer screening: the International Early Lung Cancer Action Program (I-ELCAP) study. Arch Intern Med 167: 2289-2295.
11. Russi EW, (2011) Lung cancer screening has the potential to safe lives, but shall we do it? Swiss Med Wkly 141: w13185.
12. Brenner DJ, (2004) Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer. Radiology 231: 440-445.
13. Bellomi M, Rampinelli C, Funicelli L, Veronesi G, (2006) Screening for lung cancer. Cancer Imaging 6: S9-12.
14. Aggarwal C, Somaiah N, Simon GR, (2010) Biomarkers with predictive and prognostic function in non-small cell lung cancer: ready for prime time? J Natl Compr Canc Netw 8: 822-832.
15. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
16. Boeri M, Verri C, Conte D, Roz L, Modena P, et al. (2011) MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A 108: 3713-3718.
17. Foss KM, Sima C, Ugolini D, Neri M, Allen KE, et al. (2011) miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol 6: 482-488.
18. Lin PY, Yu SL, Yang PC, (2010) MicroRNA in lung cancer. Br J Cancer 103: 1144-1148.
19. Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Morimura R, et al. (2011) Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer 105: 104-111.
20. Szafranska AE, Davison TS, John J, Cannon T, Sipos B, et al. (2007) MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 26: 4442-4452.
21. Bandi N, Zbinden S, Gugger M, Arnold M, Kocher V, et al. (2009) miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res 69: 5553-5559.
22. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, et al. (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793-1801.
23. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, et al. (2004) MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A 101: 11755-11760.
24. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198.
25. Wang Y, Rathinam R, Walch A, Alahari SK, (2009) ST14 (suppression of tumorigenicity 14) gene is a target for miR-27b, and the inhibitory effect of ST14 on cell growth is independent of miR-27b regulation. J Biol Chem 284: 23094-23106.
26. Kuehbacher A, Urbich C, Dimmeler S, (2008) Targeting microRNA expression to regulate angiogenesis. Trends Pharmacol Sci 29: 12-15.
27. Shen J, Todd NW, Zhang H, Yu L, Lingxiao X, et al. (2011) Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest 91: 579-587.
28. Keller A, Leidinger P, Borries A, Wendschlag A, Wucherpfennig F, et al. (2009) miRNAs in lung cancer- studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer 9: 353.
29. Harris TA, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ, (2008) MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci U S A 105: 1516-1521.
30. Sun Y, Bai Y, Zhang F, Wang Y, Guo Y, et al. (2010) miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7. Biochem Biophys Res Commun 391: 1483-1489.
31. Liu B, Peng XC, Zheng XL, Wang J, Qin YW, (2009) MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer 66: 169-175.
32. Subramanian J, Madadi AR, Dandona M, Williams K, Morgensztern D, et al. (2010) Review of ongoing clinical trials in non-small cell lung cancer: a status report for 2009 from the ClinicalTrials.gov website. J Thorac Oncol 5: 1116-1119.